App-Quantinova.ai

The Contribution of Serpinf2 to Tissue Plasminogen Activator Therapy for Stroke: Effects on Neuronal Cell Death, Brain Swelling, Breakdown of the Blood Brain Barrier and Mortality

Aiilyan Houng - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Long-Term Outcome of Carotid Artery Stenting in Patients of Atherosclerotic Carotid Artery Disease : A 10-year Experience of a Single Tertiary Center in Korea

Wi-Sun Ryu - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Post-tPA Care for Acute Stroke Patients; Comparison between Intensive Care Unit Admission and Stroke Unit Admission

Cynthia Steffen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Is Prophylactic Anticoagulation for Deep Venous Thrombosis Common Practice After Intracerebral Hemorrhage?

Patricia Herbers - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

dalteparin Subcutaneous

Impact of Post-Stroke Medical Complications on 30-Day Readmission Rate

Carlos Corado - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prothrombin Complex Concentrate Rapidly Reverses Coagulopathy but does not Alter Mortality in Warfarin Intracerebral Hemorrhage

Susannah Orzell - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Prothrombin complex

Declining Mortality in Cerebral Venous Thrombosis: A Systematic Review

Susanna M. Zuurbier - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Stroke Outcomes and Usage of IV Alteplase During Pregnancy in the Nationwide Inpatient Sample 2005-2010

Bichun Ouyang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Activase I.V.

Improving Nursing Documentation Compliance for Patients Treated with Alteplase Diagnosed with Ischemic Strokes

Deborah Liable - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Activase I.V.

Coated-Platelet Levels Correlate With HAS-BLED Scores in Stroke Patients With Atrial Fibrillation

Andrea Vincent - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Evithrom

Characteristics and Outcomes of Stroke Patients Transferred to Hospitals Participating in the Michigan Coverdell Acute Stroke Registry 2009-2011

Adrienne Nickels - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Quality of Care and In-Hospital Outcomes by Race and Ethnicity among Patients Hospitalized with Intracerebral Hemorrhage: Findings from 123,623 Patients in the Get With The Guidelines-Stroke Program

Robert Holloway - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Methadone hydrochloride

CT Perfusion in Acute Stroke: Substantial Value Beyond Penumbra

Michael Hewitt - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Anticoagulant Therapy in Head Injury-associated Cerebral Sinovenous Thrombosis in Children

Patcharee Komvilaisak - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Dual Antiplatelet Therapy in Addition to Post-Operative Heparin and Dextran Reduces Clinically Symptomatic Thromboembolic Events During Elective Aneurysm Coiling

Matthew Davis - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Risk Factors for Stenosis of Stents Utilized for Stent Assisted Coiling of Unruptured Intracranial Aneurysms

Hormozd Bozorgchami - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Non-invasive imaging of acute thrombosis; development of a novel factor XIIIA radiotracer

Jack Andrews - British Cardiovascular Society (BCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Relationship between pre-procedural platelet reactivity and inflammatory markers to cardiac outcomes in patients undergoing PPCI

Krishma Adatia - British Cardiovascular Society (BCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Risk Factors for Bleeding and Thrombosis Events on Veno-Arterial Extracorporeal Life Support: An ELSO Analysis

F.R. Cabezas - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient Cohort

N. Uriel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts